Core Laboratories Inc.
CLB
$11.18
$0.211.91%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -154.00K | 7.40M | 11.75M | 9.03M | 3.22M |
| Total Depreciation and Amortization | 3.72M | 3.66M | 3.68M | 3.77M | 3.84M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.94M | -144.00K | -1.41M | -4.64M | 8.35M |
| Change in Net Operating Assets | -1.84M | 9.69M | -915.00K | 8.99M | -9.88M |
| Cash from Operations | 6.66M | 20.62M | 13.10M | 17.15M | 5.53M |
| Capital Expenditure | -3.58M | -4.38M | -2.73M | -2.87M | -3.05M |
| Sale of Property, Plant, and Equipment | 1.23M | 802.00K | 133.00K | 208.00K | 593.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.12M | 20.00K | 2.11M | 1.97M | 802.00K |
| Cash from Investing | 772.00K | -3.56M | -491.00K | -687.00K | -1.66M |
| Total Debt Issued | 13.00M | 6.00M | 16.00M | 8.00M | 14.00M |
| Total Debt Repaid | -15.00M | -20.00M | -24.00M | -21.00M | -17.00M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -2.02M | -4.90M | -196.00K | -162.00K | -44.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -469.00K | -469.00K | -469.00K | -470.00K | -468.00K |
| Other Financing Activities | 9.00K | 0.00 | -162.00K | -45.00K | -568.00K |
| Cash from Financing | -4.48M | -19.37M | -8.83M | -13.68M | -4.08M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.95M | -2.32M | 3.78M | 2.78M | -207.00K |